Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Academic Article
Publication Date:
2016
abstract:
Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers.
Iris type:
1.1 Articolo in rivista
Keywords:
Amyloid beta-protein (1-42); Lewy body disease; biomarkers; cerebrospinal fluid; dementia with Lewy bodies; tau protein
List of contributors:
van Steenoven, Inger; Aarsland, Dag; Weintraub, Daniel; Londos, Elisabet; Blanc, Frédéric; van der Flier, Wiesje M; Teunissen, Charlotte E; Mollenhauer, Brit; Fladby, Tormod; Kramberger, Milica G; Bonanni, Laura; Lemstra, Afina W.
Published in: